SOLV vs. GEHC, PHG, ZBH, SNN, PEN, STVN, GKOS, NARI, IRTC, and TMDX
Should you be buying Solventum stock or one of its competitors? The main competitors of Solventum include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Smith & Nephew (SNN), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), iRhythm Technologies (IRTC), and TransMedics Group (TMDX). These companies are all part of the "medical equipment" industry.
Solventum vs. Its Competitors
GE HealthCare Technologies (NASDAQ:GEHC) and Solventum (NYSE:SOLV) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, media sentiment, community ranking, risk, institutional ownership and earnings.
82.1% of GE HealthCare Technologies shares are held by institutional investors. 0.3% of GE HealthCare Technologies shares are held by insiders. Comparatively, 0.1% of Solventum shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
GE HealthCare Technologies has higher revenue and earnings than Solventum. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks.
GE HealthCare Technologies has a net margin of 10.13% compared to Solventum's net margin of 0.00%. GE HealthCare Technologies' return on equity of 25.74% beat Solventum's return on equity.
GE HealthCare Technologies has a beta of 1.14, suggesting that its stock price is 14% more volatile than the S&P 500. Comparatively, Solventum has a beta of 0.54, suggesting that its stock price is 46% less volatile than the S&P 500.
GE HealthCare Technologies received 30 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 62.75% of users gave GE HealthCare Technologies an outperform vote while only 7.14% of users gave Solventum an outperform vote.
In the previous week, Solventum had 4 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 14 mentions for Solventum and 10 mentions for GE HealthCare Technologies. GE HealthCare Technologies' average media sentiment score of 1.21 beat Solventum's score of 0.57 indicating that GE HealthCare Technologies is being referred to more favorably in the media.
GE HealthCare Technologies currently has a consensus target price of $88.27, indicating a potential upside of 20.60%. Solventum has a consensus target price of $80.29, indicating a potential upside of 7.55%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, research analysts clearly believe GE HealthCare Technologies is more favorable than Solventum.
Summary
GE HealthCare Technologies beats Solventum on 17 of the 19 factors compared between the two stocks.
Get Solventum News Delivered to You Automatically
Sign up to receive the latest news and ratings for SOLV and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SOLV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Solventum Competitors List
Related Companies and Tools
This page (NYSE:SOLV) was last updated on 6/11/2025 by MarketBeat.com Staff
Buy SOLV Stock Free SOLV Stock Alerts